Religare Enterprises Limited has informed the Exchange regarding a press release dated May 12, 2026, titled "Religare Enterprises Limited FY26 consolidated revenue at ₹8,493.84 crore; Strategic initiatives to accelerate momentum in FY27".
RELIGARE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Religare Enterprises Limited reported FY26 consolidated revenue of ₹8,493.84 crore, up 14.7% from ₹7,405.47 crore in FY25. However, consolidated PAT declined significantly to ₹73.16 crore from ₹182.75 crore in the prior year. Q4 FY26 showed stronger revenue growth at 20.66% YoY to ₹2,473.3 crore, with PAT at ₹95.65 crore. Care Health Insurance posted gross written premium of ₹11,417 crore, up 24% YoY, gaining market share to 19.7% in the SAHI category. Religare Finvest became debt-free following RBI's removal of Corrective Action Plan restrictions. The company completed a ₹1,500 crore capital raise via convertible warrants to promoters and other investors, and the Board was substantially reconstituted with new leadership across all subsidiaries.
Revenue growth of 14.7% is positive, but the sharp decline in PAT from ₹182.75 crore to ₹73.16 crore is a concern for shareholders, indicating possible margin pressure or increased costs despite higher sales. The demerger of Financial Services business and leadership changes signal strategic restructuring that could create long-term value.